Leavell Investment Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,000
Closed -$424K – 479
2023
Q3
$424K Hold
2,000
– – 0.03% 345
2023
Q2
$385K Hold
2,000
– – 0.03% 367
2023
Q1
$405K Hold
2,000
– – 0.03% 347
2022
Q4
$257K Hold
2,000
– – 0.02% 393
2022
Q3
$274K Hold
2,000
– – 0.02% 380
2022
Q2
$354K Hold
2,000
– – 0.03% 357
2022
Q1
$288K Hold
2,000
– – 0.02% 372
2021
Q4
$309K Buy
+2,000
New +$335K 0.02% 375
2020
Q4
– Sell
-2,000
Closed -$391K – 380
2020
Q3
$391K Hold
2,000
– – 0.03% 284
2020
Q2
$340K Hold
2,000
– – 0.03% 295
2020
Q1
$231K Hold
2,000
– – 0.03% 321
2019
Q4
$229K Buy
+2,000
New +$212K 0.02% 362
2014
Q2
– Sell
-5,100
Closed -$232K – 407
2014
Q1
$232K Hold
5,100
– – 0.04% 362
2013
Q4
$203K Sell
5,100
-5,000
-50% -$204K 0.03% 380
2013
Q3
$443K Buy
10,100
+3,600
+55% +$150K 0.08% 227
2013
Q2
$204K Buy
+6,500
New +$227K 0.04% 358

Other funds holding SGEN

Leavell Investment Management's SGEN Position: Q4 2023 in Review

Leavell Investment Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,000 shares — an estimated $424K sold.

Leavell Investment Management first reported a position in SGEN in Q2 2013 and held it in 16 quarters. The position peaked at $443K in Q3 2013. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Leavell Investment Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Leavell Investment Management sold 2,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $424K.
  • Leavell Investment Management first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Leavell Investment Management's Seagen Inc. Common Stock position peaked at $443K in Q3 2013.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Leavell Investment Management's 13F filing for Q4 2023, filed 23 Jan 2024.